B7-H3 (CD276) is a type I transmembrane protein that plays a critical role in the activation or inhibition of T-cell function, is highly overexpressed in a wide range of cancers and correlates with negative clinical outcomes and poor prognosis. The gene discussed is CD276; the disease is cancer.